期刊文献+

醛糖还原酶基因多态性与糖尿病肾病的相关性研究 被引量:2

Association between polymorphisms of aldose reductase gene and diabetic nephropathy
下载PDF
导出
摘要 目的:探讨染色体7q35区醛糖还原酶(AR)基因启动子区C106T多态性与中国北方汉族人2型糖尿病肾病(DN)的相关性。方法:运用聚合酶链反应限制性片段长度多态性技术(PCR RFLP)、DNA测序技术及高浓度琼脂糖凝胶电泳分离技术,检测202例中国北方汉族人的AR基因启动子区C106T多态位点的等位基因和基因型,其中2型糖尿病(DM)患者139例,按尿微量清蛋白排泄率(UAER)分为早期DN组(61例)和非DN组(78例)两个亚组;健康成人组(CON组,63例)。各组间的等位基因频率与基因型频率比较用卡方检验,不同基因型DM患者的有关临床生化指标用(x±s)表示,比较用t检验。结果:①AR基因启动子区C106T多态位点存在T、C两种等位基因和CC、CT、TT三种基因型;②上述各种等位基因和基因型频率在DM组和CON组之间无显著性差异(P>0.05);③AR基因启动子区C106T多态位点的T等位基因和CT+TT基因型频率在早期DN组明显高于非DN组和CON组(P<0.05);④AR基因启动子区C106T多态性与DM患者的临床生化指标无相关性(P>0.05)。结论:中国北方汉族人AR基因启动子区存在C106T多态,对于2型DM患者,T等位基因可能是DN的易感等位基因,CT/TT基因型可能是DN的易感基因型。 Objective: To investigate the association between polymorphisms of the C-106T at promotor region of aldose reductase (AR) gene in chromosome 7q35 and nephropathy with type 2 diabetes in people of Han nationality in North China. Methods: A case-control study in 202 Chinese subjects (including 139 type 2 diabetes mellitus with or without nephropathy and 63 norma1 control) was performed. The genotypes and alleles of polymorphisms of C-106T at promotor region of AR gene were determined by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method with 4% agarose gel electrophoresis. The results were validated by sequencing the PCR products. Results: The frequency of the T allele and CT+TT genotypes at promotor region of AR gene was significantly higher in DN+ group than that in DN-group and control (CON) group (P<0.05), but there was no significant difference between DM and CON group (P>0.05). Conclusion: The T allele and CT/TT genotypes at promotor region of AR gene may related to nephropathy with type 2 diabetes in people of Han nationality in North China.
出处 《医学研究生学报》 CAS 2005年第4期346-348,351,共4页 Journal of Medical Postgraduates
基金 山东省科委博士基金资助项目(批准号:02BS094)
关键词 2型糖尿病 糖尿病肾病 醛糖还原酶基因 基因多态 Type 2 diabetes mellitus Diabetic nephropathy Aldose reductase gene Gene polymorphisms
  • 相关文献

参考文献7

二级参考文献2

  • 1Cai H,Diabetes Care,1998年,21卷,2195页 被引量:1
  • 2Cai H,Diabetes Care,1998年,21卷,2195页 被引量:1

共引文献41

同被引文献35

  • 1储小曼,闵佩清,张静,孔诚,蔡卫民.药物代谢酶CYP3A在中国肾移植人群的遗传多态性[J].医学研究生学报,2005,18(2):107-111. 被引量:8
  • 2Rocco MV, Bleyer A J, Burkart JM. Utilization of inpatient and outpatient resources for management of hemodialysis access complications[J]. Am J Kidney Dis, 1996, 28(2) : 250-256. 被引量:1
  • 3Taber TE, Maikranz PS, Haag BW, et al. Maintenance of adequate hemodialysis access [ J ]. ASAIO J, 1995, 41 (4) :842-846. 被引量:1
  • 4Redfem AB, Zimmerman NB. Neurologic and ischemic complications of upper extremity vascular access for dialysis [ J ]. J Hand Surg, 1995, 20(2) :199-204. 被引量:1
  • 5Uldall R, Besley ME, Thomas A, et al. Maintaining the patency of double-luman silatic jugular catheters for haemodialysis [ J ].Int J Artif Organs,1993, 16( 1 ) : 37-40. 被引量:1
  • 6Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival in diabetic patients on hemodialysis[J]. Diabetes Care, 2001, 24(5) : 909-913. 被引量:1
  • 7Ponikvar R, Ponikvar JB. Management of diabetic patients with haemodialysis, peritoneal dialysis, and renal transplantation [ J ].Nephrol Dial Transplant, 2001, 16( Suppl 6) : 94-96. 被引量:1
  • 8McMurray S, Johnson G, Davis S, et al. Diabetes education and care management significantly improve patient outcomes in the dialysis unit[J]. Am J Kidney Dis, 2002, 40(3) : 566-575. 被引量:1
  • 9Blowey DL, Balfe JW, Gupta I, et al. Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension[J]. Am J Kidney Dis, 1996, 28( 1 ) : 132-136. 被引量:1
  • 10Charra B, VoVan C, Marcelli D, et al. Diabetes mellitus in tassin, fance: remarkable transformation in incidence and outcome of ESRD in diabetes[ J]. Adv Renal Replacement Ther, 2001,8( 1 ) : 42-56. 被引量:1

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部